Literature DB >> 12761378

Immunogenicity of infliximab in Crohn's disease.

Stephen B Hanauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761378     DOI: 10.1056/NEJM200305223482121

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Therapeutic benefit of pentostatin in severe IL-10-/- colitis.

Authors:  Jeffrey B Brown; Goo Lee; Gery R Grimm; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

2.  Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab.

Authors:  Ian Gorovoy; Adar Berghoff; Laura Ferris
Journal:  Case Rep Dermatol       Date:  2009-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.